Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Download Sample Pdf
MARKET INSIGHTS
The global Soft Gelatin Capsules market was valued at USD 4.15 billion in 2024 and is projected to reach USD 5.87 billion by 2031, exhibiting a CAGR of 5.2% during the forecast period.
Soft Gelatin Capsules, commonly referred to as softgels, are one-piece, hermetically sealed capsules. They consist of a gelatin-based shell surrounding a liquid or semi-solid (inner fill) active ingredient, which can be incorporated into the outer shell matrix, the internal fill, or both. Their unique design offers significant advantages for delivering poorly soluble drugs, masking unpleasant tastes and odors, and enhancing patient compliance through easy swallowing.
This steady market growth is primarily driven by the rising global demand for dietary supplements and pharmaceuticals. Health Supplements represent the largest application segment, accounting for a dominant market share. However, the market is not without its challenges; it faces pressure from the increasing consumer preference for vegetarian and vegan alternatives, which is fueling the growth of the Non-animal Type segment. From a regional perspective, the Asia-Pacific region holds the largest market share, exceeding 30%, due to its large population and growing health consciousness. The market is also characterized by a high level of consolidation, with the top five manufacturers collectively controlling over 40% of the global sales. Leading players such as Catalent, Aenova, and Lonza (Capsugel) continue to innovate in manufacturing technologies to maintain their competitive edge in this evolving landscape.
Rising Consumer Preference for Easy-to-Swallow Dosage Forms
The global soft gelatin capsules market is significantly driven by the growing consumer inclination towards convenient and patient-friendly pharmaceutical formulations. Softgels are easier to swallow than tablets and powders, which is particularly important for pediatric and geriatric populations. This improved patient compliance is a key factor for pharmaceutical companies when developing new products.
Expanding Applications in Nutraceuticals and Cosmeceuticals
The market is further propelled by the expanding use of soft gelatin capsules beyond traditional pharmaceuticals. The booming nutraceutical industry utilizes softgels for oils, vitamins, and supplements due to their superior bioavailability and ability to mask unpleasant tastes. This diversification into high-growth segments creates sustained demand.
The global nutraceuticals market is projected to surpass USD 600 billion by 2030, directly fueling the demand for advanced delivery systems like softgel capsules.
Technological advancements in manufacturing, such as the development of vegetarian and non-animal-based shell materials, are also opening new avenues and attracting a wider consumer base, including vegetarians and those with specific dietary restrictions.
MARKET CHALLENGES
High Production Costs and Complex Manufacturing
The production of soft gelatin capsules is a complex process requiring specialized equipment and controlled environmental conditions, leading to higher manufacturing costs compared to tablets or hard capsules. This cost factor can be a barrier for small and medium-sized enterprises looking to enter the market.
Other Challenges
Stability and Storage Sensitivity
Softgel shells are sensitive to extreme temperatures and humidity, which can lead to stability issues like softening, sticking, or leakage. This necessitates stringent storage and supply chain conditions, increasing logistical challenges and costs.
Limited Compatibility with Certain Formulations
Not all active pharmaceutical ingredients (APIs) are suitable for encapsulation in softgels, particularly hygroscopic or deliquescent substances that can interact with the gelatin shell, limiting the scope of application.
Stringent Regulatory Requirements and Compliance
The soft gelatin capsules market faces significant restraints due to stringent regulatory standards imposed by agencies like the FDA and EMA. The approval process for new softgel formulations is rigorous, time-consuming, and costly, which can delay market entry and increase development expenses for manufacturers.
Competition from Alternative Drug Delivery Systems
The market growth is also tempered by strong competition from other advanced drug delivery systems, such as orally disintegrating tablets, chewable tablets, and gummies. These alternatives often offer similar patient compliance benefits at a potentially lower cost, challenging the market share of softgels.
Growth in Personalized Medicine and Targeted Therapies
The rise of personalized medicine presents a significant opportunity for the softgel market. Softgels can be engineered for modified release, such as sustained or targeted delivery, making them ideal for complex biologic drugs and personalized treatment regimens that require precise dosing and enhanced efficacy.
Expansion in Emerging Markets
Emerging economies in Asia-Pacific and Latin America offer substantial growth potential. Increasing healthcare expenditure, growing middle-class populations with higher disposable income, and rising health awareness are driving the demand for pharmaceutical and nutraceutical products, including softgel capsules.
Innovation in Shell Materials and Formulations
Research and development into new, innovative shell materials, such as starch-based or pullulan-based vegetarian capsules, addresses dietary and cultural preferences. This innovation opens up new market segments and attracts environmentally conscious consumers, creating fresh growth avenues.
Segment Analysis:| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
Gelatin Type holds the dominant position in the market, favored for its well-established manufacturing processes, excellent barrier properties, and high consumer acceptance derived from decades of reliable use in pharmaceuticals and supplements. The primary driver for this segment is its ability to effectively encapsulate a wide range of oil-based and lipid-soluble active ingredients, providing superior stability and bioavailability. While the Non-animal Type segment, which includes plant-derived alternatives like starch or pullulan, is experiencing notable growth due to rising demand from vegetarian, vegan, and certain religious consumer groups seeking halal or kosher certified products, it is still considered a niche market. The growth of non-animal capsules is propelled by continuous material science innovation aimed at matching the functional performance of traditional gelatin, though widespread adoption faces challenges related to production scalability and cost competitiveness. |
| By Application |
|
Health Supplements represent the most significant application segment, driven by the global consumer shift towards proactive wellness and preventive healthcare. This segment extensively utilizes softgels for vitamins, minerals, omega-3 fatty acids, and herbal extracts due to their ease of swallowing, ability to mask unpleasant tastes and odors, and protection of sensitive ingredients from oxidation. The Pharmaceutical application is also a major segment, where softgels are valued for precise dosing and enhanced patient compliance, particularly for pediatric and geriatric populations. Pharmaceutical applications often involve prescription drugs that benefit from the improved bioavailability offered by liquid-filled capsules. The Others category, which includes niche applications like cosmetic nutraceuticals and certain over-the-counter products, shows potential for innovation but remains smaller in scale compared to the two leading segments, serving specialized market needs. |
| By End User |
|
Contract Manufacturing Organizations (CMOs) are the leading end-user segment, as many companies opt to outsource softgel production to specialized manufacturers who possess the necessary technical expertise, regulatory compliance knowledge, and high-capacity, capital-intensive equipment. This model offers flexibility and cost-efficiency, especially for smaller brands and companies launching new products. In-house Pharmaceutical Companies with large-scale, consistent product lines often maintain their own manufacturing capabilities to ensure stringent quality control and protect proprietary formulations. Nutraceutical Brands represent a highly dynamic segment, driving demand for innovative delivery formats and customized solutions to differentiate their products in a crowded market. The trend towards outsourcing is particularly strong among nutraceutical brands that focus on marketing and distribution while leveraging the specialized capabilities of CMOs for production. |
| By Shell Characteristics |
|
Standard Gelatin Shells constitute the vast majority of the market, serving as the default and most economical option for a wide array of applications where basic protection and delivery are the primary requirements. Their widespread use is attributed to proven reliability and straightforward manufacturing. Enteric-coated Shells are a critical and growing sub-segment designed to resist dissolution in the acidic environment of the stomach, ensuring the active ingredient is released in the intestine. This is essential for acid-sensitive drugs and supplements, enhancing their efficacy and stability. Specialty Shells, including opaque shells for light-sensitive actives like Vitamin A or flavored shells to improve palatability, represent a value-added segment driven by the need for product differentiation and addressing specific formulation challenges, illustrating the market's move towards more sophisticated and targeted delivery solutions. |
| By Therapeutic Area |
|
General Health & Wellness is the dominant therapeutic area, encompassing a broad spectrum of multivitamins, minerals, and general dietary supplements consumed by health-conscious individuals for maintaining daily wellness. This segment benefits from high consumer awareness and the pervasive trend of self-care. Cardiovascular Health is a significant and stable segment, heavily reliant on softgels for delivering omega-3 fatty acids (EPA and DHA) and coenzyme Q10, where the lipid-soluble nature of these actives makes softgels the ideal delivery system for ensuring optimal absorption. Other Targeted Therapies include applications in areas like joint health (glucosamine, chondroitin), eye health (lutein), and specific pharmaceutical drugs. This segment demonstrates the versatility of softgels in addressing specialized health needs, with growth driven by an aging global population and increasing focus on condition-specific supplementation. |
A Market Dominated by Global Contract Development and Manufacturing Organizations (CDMOs)
The global Soft Gelatin Capsules market is characterized by a consolidated landscape, with the top five manufacturers collectively holding over 40% of the sales market share. The market is led by global contract development and manufacturing organizations (CDMOs) that offer end-to-end services from formulation development to large-scale commercial manufacturing. Catalent, Inc. stands as a dominant player, bolstered by its acquisition of the softgel business of Patheon (now part of Thermo Fisher Scientific), which significantly expanded its global footprint and technological capabilities. Aenova Group and Lonza (through its Capsugel division) are other major global entities with extensive manufacturing networks, particularly strong in the European and North American markets. These leaders compete on the basis of technological innovation, manufacturing capacity, regulatory expertise, and the ability to serve the stringent requirements of the pharmaceutical and health supplement industries worldwide.
Beyond the dominant global CDMOs, the market includes a diverse array of significant regional and specialized players. Companies like Procaps in Latin America and Sirio Pharma in China have established strong positions in their respective regions, catering to local demand and expanding their international presence. Other prominent participants include Strides Pharma Science, which has a focus on generic pharmaceuticals, and specialized manufacturers like Soft Gel Technologies and EuroCaps. The market also features major brand-owned manufacturers such as Amway and Pharmavite (producer of Nature Made supplements), which integrate backward into softgel production for their proprietary products. The Asia-Pacific region is a key growth area, with numerous players like Baihe Biotech, Ziguang Group, and By-Health driving competition with cost-effective manufacturing and a focus on the burgeoning health supplements sector.
List of Key Soft Gelatin Capsules Companies ProfiledCatalent
Natures Bounty
Patheon (Thermo Fisher Scientific)
Aland
EuroCaps
Captek
Strides Pharma Science
Soft Gel Technologies
Amway
Sirio Pharma
Baihe Biotech
Ziguang Group
The global soft gelatin capsules market is demonstrating robust growth, with its valuation increasing from $4,150 million in 2024 to a projected $5,868 million by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 5.2%. This consistent expansion is underpinned by the versatility and effectiveness of softgels in the pharmaceutical and health supplements sectors. The Asia-Pacific region leads global sales, accounting for over 30% of the market share, driven by rising health awareness, increasing disposable income, and expanding pharmaceutical manufacturing capabilities. Europe follows as the second-largest regional market. The industry is also characterized by a degree of consolidation, with the top five manufacturers including Catalent, Aenova, and Patheon (Thermo Fisher Scientific) collectively holding over 40% of the total market share. This trend points to a competitive landscape where scale, technological innovation, and global reach are increasingly critical for success.
Other TrendsDominance of Gelatin-Based Capsules and Health Supplement Applications
The market is overwhelmingly dominated by traditional gelatin-type capsules, which command a sales market share exceeding 85%. This preference is due to gelatin's proven performance in encapsulation, stability, and consumer familiarity. However, there is a parallel, growing interest in non-animal alternatives, which presents a significant area for future development. In terms of application, the health supplements segment is the largest and fastest-growing driver of demand, followed closely by the pharmaceutical industry. The popularity of dietary supplements, vitamins, and omega-3 oils in an easy-to-swallow softgel format is a key factor fueling this trend, as consumers increasingly seek convenient and effective delivery systems for nutritional products.
Focus on Technological Innovation and Regional OpportunitiesManufacturers are increasingly focused on technological advancements to enhance production efficiency and capsule functionality. Innovations include the development of specialized formulations for bioavailability enhancement and the creation of unique shapes and sizes to improve brand differentiation. Beyond the established markets, significant growth potential exists in emerging economies within Asia and South America. These regions offer untapped markets and rising local manufacturing, representing a strategic focus for investment and expansion by leading players. Concurrently, companies must navigate challenges such as fluctuating raw material costs, stringent regulatory requirements, and the evolving demand for vegetarian and halal-certified capsule options, which are influencing long-term strategic planning.
Regional Analysis: Soft Gelatin Capsules MarketEurope
Europe represents a highly significant and sophisticated market for soft gelatin capsules, characterized by a strong pharmaceutical industry and a health-conscious population. The market is driven by similar factors to North America, including a preference for advanced drug delivery systems and a well-established nutraceutical sector. Countries like Germany, France, and the United Kingdom are major contributors, with a focus on producing high-value, complex formulations. The region's regulatory environment, guided by the European Medicines Agency (EMA), is rigorous, ensuring high standards of production and safety. There is a growing trend towards plant-based and halal-certified softgel capsules to cater to diverse consumer preferences and ethical choices. However, the market dynamics are also shaped by cost-containment pressures from national healthcare systems, which can influence pricing strategies for pharmaceutical softgels.
Asia-Pacific
The Asia-Pacific region is the fastest-growing market for soft gelatin capsules, fueled by rising disposable incomes, expanding healthcare access, and growing awareness of preventive healthcare. Countries such as China, India, and Japan are at the forefront of this growth. The region benefits from a large manufacturing base with cost-effective production capabilities, making it a global hub for contract manufacturing. There is increasing domestic consumption of vitamins, minerals, and traditional medicine formulations in softgel form. While the market is expanding rapidly, it is also highly competitive and fragmented, with a mix of large multinational corporations and local manufacturers. Regulatory harmonization across different countries remains a challenge, but ongoing improvements in standards are enhancing market quality and attracting further investment.
South America
The South American market for soft gelatin capsules is evolving, with Brazil and Argentina being the primary drivers. Growth is supported by an expanding middle class and improving healthcare infrastructure. The market is predominantly focused on over-the-counter vitamins and dietary supplements. Local production capabilities are developing, but the region still relies significantly on imports for advanced formulations and machinery. Economic volatility and fluctuating currency values in some countries can pose challenges for market stability and investment. Nevertheless, the long-term outlook remains positive as consumer health awareness continues to rise, creating new opportunities for market penetration and localized production.
Middle East & Africa
The Middle East and Africa region presents a nascent but promising market for soft gelatin capsules. Growth is primarily concentrated in the Gulf Cooperation Council (GCC) countries, such as Saudi Arabia and the UAE, where high per capita income and a focus on premium healthcare products drive demand. The market is largely import-dependent, with products sourced from Europe and Asia. There is a specific demand for halal-certified pharmaceutical and nutraceutical products, which softgel manufacturers are increasingly catering to. In Africa, the market is still in early stages of development, with growth potential tied to economic development and healthcare investment. Challenges include fragmented distribution networks and varying regulatory standards across the continent.
This market research report offers a holistic overview of global and regional markets for the forecast period 20252031. It presents accurate and actionable insights based on a blend of primary and secondary research.
Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
Segmentation Analysis
By product type (Gelatin Type vs Non-animal Type)
By application (Health Supplements, Pharmaceutical, Others)
By distribution channel
Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
Competitive Landscape
Company profiles and market share analysis (top 5 control 40% market)
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
Technology & Innovation
Emerging vegan alternatives and formulation technologies
Manufacturing process improvements
Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
Opportunities & Recommendations
High-growth segments (Asia-Pacific, vegan alternatives)
Investment hotspots
Strategic suggestions for stakeholders
Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
Pharmaceutical companies
Dietary supplement manufacturers
Contract manufacturers
Investors and consultants
Raw material suppliers
-> Global soft gelatin capsules market was valued at USD 4.15 billion in 2024 and is projected to reach USD 5.87 billion by 2031.
Which key companies operate in Global Soft Gelatin Capsules Market?
-> Key players include Catalent, Aenova, Nature's Bounty, Procaps, and Patheon (Thermo Fisher Scientific), with top 5 controlling over 40% market share.
-> Key growth drivers include rising demand for dietary supplements and pharmaceutical applications.
-> Asia-Pacific holds the largest market share (over 30%), followed by Europe.
-> Emerging trends include vegan alternatives (Non-animal Type) and manufacturing technology innovations.
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates